Results 11 to 20 of about 28,392 (204)

Prophylactic Olanzapine Versus Placebo in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Protocol for a Multicenter Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) Trial. [PDF]

Acta Anaesthesiol Scand
ABSTRACT Background Delirium is a frequent complication in comatose Out‐of‐Hospital Cardiac Arrest (OHCA) survivors requiring postresuscitation intensive care and is associated with higher mortality and longer hospitalization. Despite this, there is no established pharmacologic strategy for delirium prevention in OHCA survivors.
Liebetrau B, Grejs AM, Meyer MAS, Andersen LPK, Möller S, Mølstrøm S, Møller JE, Schmidt H, Christensen S, Kjærgaard J, Hassager C, Rasmussen BS, Andreasen JB.   +12 more
europepmc   +2 more sources

The Danish Out-of-Hospital Cardiac Arrest Trial: A Statistical Analysis Plan. [PDF]

Acta Anaesthesiol Scand
ABSTRACT Background Post‐cardiac arrest care for patients resuscitated from out‐of‐hospital cardiac arrest (OHCA) includes multiple pharmacological and physiological interventions, yet optimal strategies to reduce post‐cardiac arrest syndrome–related morbidity and mortality remain uncertain.
Mølstrøm S, Møller JE, Schmidt H, Grejs AM, Christensen S, Kjærgaard J, Hassager C, Meyer MAS, Andersen LPK, Rasmussen BS, Andreasen JB, Möller S.   +11 more
europepmc   +2 more sources

Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data

BMC Psychiatry, 2012
Background To treat acute schizophrenia, a long-acting injectable antipsychotic needs a rapid onset of action and therapeutic profile similar to that of oral agents.
Detke Holland C, Zhao Fangyi, Witte Michael M   +2 more
doaj   +1 more source

Olanzapine-induced hiccups： a case report

Sichuan jingshen weisheng, 2021
The case report aims to raise the concern of clinicians about hiccups as an adverse reaction in olanzapine treatment. A 47-year-old male patient with epileptic mental disorder appeared symptoms of persistent hiccups on the fourth day of treatment with ...
Sun Zhenxiao, Xu Chunmei, Zhao Lin
doaj   +1 more source

Olanzapine induced tardive dyskinesia

Medical Journal of Dr. D.Y. Patil University, 2014
Olanzapine is considered to have significantly less risk of tardive dyskinesia (TD) compared to first generation antipsychotics. We describe two patients who developed TD after prolonged use of olanzapine.
Rudraprosad Chakraborty, Arunima Chatterjee, Suprakash Chaudhury   +2 more
doaj   +1 more source

Olanzapine

Reactions Weekly, 2006
europepmc   +4 more sources

Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes

eLife, 2020
Second-generation antipsychotics are widely used to medicate patients with schizophrenia, but may cause metabolic side effects such as diabetes, which has been considered to result from obesity-associated insulin resistance.
Satoshi Ninagawa, Seiichiro Tada, Masaki Okumura, Kenta Inoguchi, Misaki Kinoshita, Shingo Kanemura, Koshi Imami, Hajime Umezawa, Tokiro Ishikawa, Robert B Mackin, Seiji Torii, Yasushi Ishihama, Kenji Inaba, Takayuki Anazawa, Takahiko Nagamine, Kazutoshi Mori   +15 more
doaj   +1 more source

Teratogenicity with Olanzapine

Indian Journal of Psychological Medicine, 2014
Olanzapine, a 2(nd) generation antipsychotic, is in use in the clinical practice for nearly a decade and a half now. It is classified as a category C drug with very few reports of its toxic effects on the fetus. In general, the risk benefit analysis warrants its use in pregnancy.
Sathya Prakash, Rakesh Kumar Chadda
openaire   +4 more sources

Olanzapine pamoate use for schizophrenia: Retrospective records based study from a tertiary care hospital

Indian Journal of Psychological Medicine, 2020
Background: Little is known from India about the experience of using olanzapine long-acting antipsychotic injectables (LAI). In this background, this study aimed to evaluate the clinical profile of patients suffering from schizophrenia who were ...
Sandeep Grover, Himanshu Singla, Subho Chakrabarti, Ajit Avasthi   +3 more
doaj   +1 more source

Hematological safety of olanzapine

Psychiatria i Psychologia Kliniczna, 2016
Olanzapine is an atypical antipsychotic medication, previously expected to be safe in terms of hematological side effects and considered an alternative choice to clozapine in patients who develop hematotoxicities.
Asem A Alageel, Eisha M Gaffas
doaj   +1 more source